Tuesday 6th June 2023 |
Text too small? |
Synlait Milk Limited (Synlait) is extremely pleased to announce that the State Administration for Market Regulation (SAMR) has notified it of the successful re-registration of The a2 Milk Company’s Chinese labelled 至初® Infant Formula (stages one, two and three) at its Dunsandel facility, which will allow it to manufacture and export this product for the China market until September 2027.
As the manufacturer of those products, the SAMR registration is held by Synlait and attached to its Dunsandel facility. The re-registration is pivotal for the ongoing success of the manufacturing and supply agreement that Synlait and The a2 Milk Company have.
Synlait CEO Grant Watson commented: “We are thrilled to have achieved this significant milestone, which is pivotal to the long-term success of our Advanced Nutrition business. Our shareholders, staff, customers, and farmer suppliers all benefit from the certainty of today’s re-registration and continued China market access.”
“Synlait and The a2 Milk Company have a long-standing and complementary partnership, and we look forward to continuing to support their China growth ambitions. The re-registration is a very important milestone and we have worked hard together to ensure its success. We thank SAMR and the Ministry for Primary Industries, for their support during this process.”
No comments yet
SKC - Appointment of Managing Director Adelaide
Devon Funds Morning Note - 13 September 2024
BRM - BROKER HANDLING FEE ON BARRAMUNDI WARRANTS
BAI - Results of Being AI Limited Annual Meeting
Meridian Energy monthly operating report for August 2024
Ryman Healthcare debt facilities update
Turners makes a strategic growth investment in My Auto Shop
September 10th Morning Report
ENS - Prospective Buyback of Securities On-Market
TWR - Comprehensive market update as strategic review concludes